Paige is enhancing its suite of AI-enabled solutions designed to support pathologists in the diagnosis of breast cancer while decreasing subjectivity and the tedium of manual analysis. Paige Breast ...

HER2-positive breast cancer accounts for about 20% of breast cancer cases and is generally associated with more aggressive ...

Analysis of total tumor load of sentinel lymph node as a prognostic factor in patients with early breast cancer. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...

ArteraAI Breast is designed to stratify breast cancer patients into high- and low-risk groups to guide treatment decisions.

AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance ...

Digital pathology company Paige has launched a new artificial-intelligence-powered tool for researchers designed to help catch cases of breast cancer that have metastasized to nearby lymph nodes. The ...

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer. In addition, they explored their clinical ...

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy We reviewed patients ...

Welcome to the Breast Imaging Fellowship Program. We are passionate about breast health, and this fellowship provides trainees with high-quality education and clinical training in all aspects of ...

The test imputes risk of metastasis in early-stage hormone receptor-positive, HER2-negative breast cancers to help tailor treatment.